A new deal offers a lifeline for TCRR stock and a compatible investment for Adaptimmune. Both companies are targeting solid cancer tumors. More
Articles
AMC Stock Alert: ISS Backs APE Conversion Ahead of March 14 Vote
AMC raised cash with preferred shares, bypassing limits on common stock from its existing shareholders. CEO Adam Aron insists the move has saved the company and prospects are now excellent. More